Andreas Pahl

Prof. Dr. Andreas Pahl serves as Professor and Chair of Pharmacology and Toxicology at the Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander University Erlangen-Nuremberg (FAU). He is actively affiliated with the FAU Research Center for New Drugs (FAU NeW), contributing to pharmaceutical innovation and translational research initiatives at this leading German university.

His research spans core domains of Pharmacology and Toxicology, with specialized focus on experimental drug mechanisms and clinical applications. This encompasses rigorous investigation of therapeutic efficacy, safety profiling, and adverse effect characterization, bridging laboratory discoveries with patient-oriented outcomes. His work supports FAU's mission in advancing evidence-based drug development.

Prof. Pahl's leadership within the FAU Research Center for New Drugs (FAU NeW) drives collaborative projects targeting novel therapeutics. This interdisciplinary hub connects academic researchers with industry partners to accelerate preclinical validation and clinical translation, positioning him at the forefront of pharmaceutical innovation in Germany's research-intensive academic ecosystem.